Fundamental Analysis

ASTEC LIFE SCIENCES

Ticker : 533138
BUY: Rs 553.50
Target: Rs 615

Astec Lifesciences Limited is a company engaged in agrochemicals, including fungicides and herbicides business. It manufactures a range of agrochemical active ingredients and pharmaceutical intermediates. On a quarterly consolidated front, the company reported net sales of Rs 180.57 crore in Q4FY20, up by 35 per cent from Rs 133.76 crore in the same period for the previous fiscal year. The operating profit of the company rose substantially as well and was reported at Rs 47.93 crore in Q4FY20, expanding by 66.16 per cent from Rs 28.84 crore in Q4FY19. Net profit after tax more than doubled in Q4FY20 and was reported at Rs 31.18 crore, from Rs 12.73 crore in the corresponding period for the previous fiscal year,showcasing a growth of 145.02 per cent. Astec Lifesciences has zero promoter pledge with low-debt. Owing to this and the company’s impressive financial performance for the recent quarter, we recommend a BUY.